170773 ⎘
Reference solutions for assays of biological material
Sub-classes:VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION
#2REAGENTS FOR POTENTIOMETRIC MAGNESIUM ION SELECTIVE ELECTRODE SENSORS AND METHODS OF PRODUCTION AND USE THEREOF
#3METHOD FOR MEASURING ACTIVITY OR CONCENTRATION OF ALKALINE PHOSPHATASE CONTAINED IN EXTRACELLULAR VESICLE IN SAMPLE, POLYPEPTIDE MOLECULE, METHOD FOR PRODUCING THE SAME, AND CALIBRATOR
#4READY-TO-CONSTITUTE ANALYTICAL PLATFORMS FOR CHEMICAL ANALYSES AND QUANTIFICATION OF ANALYTES IN BIOLOGICAL SAMPLES
#5METHOD FOR STABILIZING HEMOGLOBIN A2 AND HEMOGLOBIN F, METHOD OF PRODUCING HEMOGLOBIN SOLUTION, AND HEMOGLOBIN SOLUTION
#6STANDARDISATION OF NUCLEOSOME ASSAYS USING BIOLOGICALLY DERIVED CALIBRANTS
#7STANDARD FOR GLYCOPROFILING OF PROTEINS
#8Quantitative Controls and Calibrators for Cellular Analytes
#9REAGENTS FOR POTENTIOMETRIC MAGNESIUM ION SELECTIVE ELECTRODE SENSORS AND METHODS OF PRODUCTION AND USE THEREOF
#10CHITINASE PROTEINS IN NEUROLOGIC DISEASE
#11Method for Diagnosing and Assessing Endometriosis
#12METHOD FOR THE ABSOLUTE QUANTIFICATION OF NATURALLY PROCESSED HLA-RESTRICTED CANCER PEPTIDES
#13METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING SUBJECTS AT RISK FOR POOR CAR T CELL THERAPY RESPONSE
#14METHOD FOR CREATING CALIBRATION CURVE AND METHOD FOR MEASURING AMYLOID ß-RELATED PEPTIDE
#15PROSTATE ANTIGEN STANDARDS AND USES THEREOF
#16METHOD FOR MEASURING ACTIVITY OF ALKALINE PHOSPHATEASE CONTAINED IN EXTRACELLULAR VESICLE, CALIBRATOR, AND CONJUGATE
#17UNIVERSAL CALIBRATION FOR QUANTITATIVE MASS SPECTROMETRY
#18METHOD FOR TESTING POSSIBILITY OF HAVING CONTRACTED PROSTATE CANCER
#19METHOD FOR STABILIZING HEMOGLOBIN
#20INTERFERENCE MONITORING FOR PROVIDING A VERIFIED ANALYTE MEASUREMENT
#21Screening method
#22PREDETERMINED CALIBRATION CURVE
#23COMPOSITIONS AND METHODS FOR CALIBRATION AND QUALITY CONTROL
#24METHODS OF SCREENING FOR CONDENSATE-ASSOCIATED SPECIFICITY AND USES THEREOF
#25Method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200
#26Method for detection and quantification of CLN3 protein
#27Anti-SARS-CoV-2 fusion peptides
#28FUSION PROTEIN AND HIGH-DENSITY LIPOPROTEIN MEASUREMENT KIT USING SAME
#29MICROBIAL CYTOMETRIC MOCK COMMUNITIES AND USE THEREOF AS STANDARD IN FLOW CYTOMETRY
#30ASSESSMENT METHOD AND DIAGNOSTIC KIT FOR PREDICTING LONG-TERM PROGNOSIS OF ACUTE CORONARY SYNDROME ASSOCIATED WITH DEPRESSION
#31Composition of a bilirubin stock and a method of preparation thereof
#32METHOD OF TREATING CANCER WITH TELOTRISAT OR A PRODRUG THEREOF
#33CALIBRATOR FOR IMMUNOASSAYS
#34Inspection Method Enabling Specific Diagnosis of Pathological State of Diabetic Nephropathy at Early Stage
#35Gasotransmitter metabolites and Alzheimer's disease
#36METHOD FOR EVALUATING ANTI-INFECTIVE DRUGS, VACCINES, ETC. USING IMMORTALIZED MONOCYTIC CELLS AND INDUCED CELLS
#37BIOMARKER FOR DIAGNOSING AUTISM SPECTRUM DISORDER
#38METHOD FOR DIAGNOSING DEMENTIA OR DETERMINING THE RISK OF DEVELOPING DEMENTIA
#39PROTEIN AND PEPTIDE BIOMARKERS FOR TRAUMATIC INJURY TO THE CENTRAL NERVOUS SYSTEM
#40METHOD FOR DIAGNOSIS OF LYME ARTHRITIS, METHOD FOR DIFFERENTIAL DIAGNOSIS OF LYME ARTHRITIS, LYSOPHOSPHATIDYLETHANOLAMINE FOR USE AS BIOMARKER, KIT FOR DIAGNOSIS OF LYME ARTHRITIS AND KIT FOR DIFFERENTIAL DIAGNOSIS OF LYME ARTHRITIS
#41BIOMARKERS FOR COLORECTAL CANCER
#42DIAGNOSTIC AND THERAPEUTIC METHODS FOR KIDNEY CANCER
#43LEUKOCYTE RECRUITMENT IN INFECTIOUS DISEASE
#44COMPOSITIONS AND METHODS FOR TREATING VASCULAR DISEASE IN SELECTED PATIENTS
#45Chitinase proteins in neurologic disease
#46Methods and compositions for identifying and treating subjects at risk for poor CAR T cell therapy response
#47Reagents for potentiometric magnesium ion selective electrode sensors and methods of production and use thereof
#48CANCER EPIGENETIC PROFILING
#49Serum Biomarkers
#50Methods of determining protein or peptide concentration and uses thereof
#51Methods of screening for condensate-associated specificity and uses thereof
#52ASSAYS FOR CELL-BASED THERAPIES OR TREATMENTS
#53BIOMARKERS AND METHODS FOR EVALUATION AND TREATMENT OF EPILEPTIC VS NON-EPILEPTIC SEIZURES / NO SEIZURES / PSYCHOGENIC NON-EPILEPTIC SEIZURES
#54BIOMARKERS OF BREAST CANCER
#55CIRCULATING BMP10 (BONE MORPHOGENIC PROTEIN 10) IN THE ASSESSMENT OF ATRIAL FIBRILLATION
#56Methods for quantitating extra-cellular vesicle surface markers, and compositions for practicing the same
#57DISTINGUISHING CANCER FROM NEUROLOGICAL RISK USING COPY NUMBER VARIATION
#58CIRCULATING TFPI-2 (TISSUE FACTOR PATHWAY INHIBITOR 2) IN THE ASSESSMENT OF ATRIAL FIBRILLATION AND ANTICOAGULATION THERAPY
#59OVARIAN CANCER BIOMARKER AND METHODS OF USING SAME
#60CES-2 (CARBOXYLESTERASE-2) FOR THE ASSESSMENT OF AFIB RELATED STROKE
#61METHODS FOR PREDICTING OUTCOME AND TREATMENT OF PATIENTS SUFFERING FROM PROSTATE CANCER OR BREAST CANCER
#62Methods for HPLC analysis
#63PREDICTION OF PREECLAMPSIA BASED ON IGFBP-7
#64METHOD OF ASSESSING WOUND HEALING POTENCY OF A MESENCHYMAL STEM POPULATION AND RELATED METHODS OF SELECTING MESENCHYMAL STEM CELLS AND IDENTIFYING TISSUE AS STARTING MATERIAL FOR PRODUCING A MESENCHYMAL STEM CELL POPULATION
#65Control of pH in aqueous urea-containing solutions utilizing amino acid-containing compositions
#66Method for diagnosing and assessing endometriosis
#67Methods for identifying and monitoring pregnant women at risk of preeclampsia
#68METHODS, KITS AND DEVICES FOR MEASURING EXTRACELLULAR PYRIDINE NUCLEOTIDE
#69Screening method
#70METHOD AND KIT FOR ASSISTING DIAGNOSIS OF DISEASE IN SUBJECT
#71Diagnostic and prognostic methods for estrogen-induced cancers
#72METHOD FOR DIAGNOSING OR MONITORING CONDITIONS CHARACTERIZED BY ABNORMAL TEMPORAL VARIATIONS AND METHOD OF NORMALIZING EPIGENETIC DATA TO COMPENSATE FOR TEMPORAL VARIATIONS
#73SRM/MRM Assay for the Tumor Necrosis Factor Receptor Superfamily Member 8 (CD30) Protein
#74Method for the absolute quantification of naturally processed hla-restricted cancer peptides
#75Bag containing a reference fluid
#76OPRT expression and cancer treatment outcome
#77Urinalysis device and dry reagent for quantitative urinalysis
#78Urinalysis device and dry reagent for quantitative urinalysis
#79ANTI-T. CRUZI ANTIBODIES AND METHODS OF USE
#80Thyroglobulin quantitation by mass spectroscopy
#81Control of pH in aqueous urea-containing solutions utilizing amino acid-containing compositions
#82Reagents for potentiometric magnesium ion selective electrode sensors and methods of production and use thereof
#83Mass-spectrometric resistance determination by growth measurement
#84Method for correcting Crea sensor for calcium inhibition
#85Thyroglobulin quantitation by mass spectroscopy
#86Method of using an electrochemical test sensor
#87STANDARD CELL SUSPENSION
#88Method for assessing protein identity and stability
#89Prostate antigen standards and uses thereof
#90Method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200
#91Quality control marker and its use in cordyceps species authentication
#92Thyroglobulin quantitation by mass spectroscopy
#93Bag containing a reference fluid
#94SRM/MRM Assays
#95Antibody
#96Reagents for potentiometric magnesium ion selective electrode sensors and methods of production and use thereof
#97Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards
#98HOMOGENOUS POPULATIONS OF MOLECULES
#99Customized quality controls for analytical assays
#100Anti-antibodies and methods of use
#101Urinalysis device and dry reagent for quantitative urinalysis
#102Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
#103Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
#104Formalin-fixed isotope-labeled reference standards and methods for fabrication and use thereof
#105Methods for universal determination of anticoagulant activity
#106Systems and methods for artificial test strip controls
#107Mass spectrometric assays for peptides
#108Prostate antigen standards and uses thereof
#109Quantitative Controls and Calibrators for Cellular Analytes
#110Devices and methods for testing analytes
#111METHOD FOR PREPARATION OF PURIFIED ALLERGEN POSITIVE CONTROL SERUM
#112Method for In Vitro Quantifying Allo-Antibodies, Auto-Antibodies and/or Therapeutic Antibodies
#113MSIA-SRM ASSAY FOR BIOMARKER ANALYSIS
#114Method for assessing protein identity and stability
#115Calibration method for photometry
#116Mass-spectrometric resistance determination by growth measurement
#117Customized quality controls for analytical assays
#118REFERENCE STANDARD FOR DIAGNOSTIC APPLICATIONS
#119Thyroglobulin quantitation by mass spectroscopy
#120Control of pH in aqueous urea-containing solutions utilizing amino acid-containing compositions
#121Platelet biomarkers in cancer diagnosis
#122USING GALECTIN-BINDING CARBOHYDRATES AS PREDICTORS OF MELANOMA PROGRESSION AND METASTASIS
#123Glycoform detection method and glycoform detection device
#124NEUROFURANS-INDICES OF OXIDANT STRESS
#125LYOPHILISED DABIGATRAN
#126Method for the direct detection and/or quantification of at least one compound with a molecular weight of at least 200
#127Anti-antibodies and methods of use
#128Isotopic Labelling of Proteins
#129STAIN, PROCESS FOR STAINING AND ACQUIRING NORMALIZED SIGNAL
#130Method of using an electrochemical test sensor
#131Method of using a control solution and preparing for testing using the same
#132Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry
#133Mass spectrometric assays for peptides
#134IMMUNOASSAY STANDARDS AND MEASUREMENT OF CLINICAL BIOMARKERS USING INTRA-ASSAY CALIBRATION STANDARDS
#135Formalin-fixed isotope-labeled reference standards and methods for fabrication and use thereof
#136Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
#137Homogenous populations of molecules
#138Anti-antibodies and methods of use
#139Lyophilised dabigatran
#140Methods for measuring concentrations of biomolecules
#141Homogenous Populations of Molecules
#142NEUROFURANS-INDICES OF OXIDANT STRESS
#143Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry
#144Polypeptide as standard for proteome analysis
#145Use of a reference source with adaptive optics in biological microscopy
#146Caspofungin free of caspofungin impurity A
#147Anti-T. Cruzi Antibodies and Methods of Use
#148Calibrator For Immunoassays
#149Control markers for auto-detection of control solution and method of use
#150Standard
#151Normalisation of microarray data based on hybridisation with an internal reference
#152Cartridge for monitoring the function of a device for testing blood platelet function, method for function monitoring, and use of a test fluid
#153Homogeneous populations of molecules
#154Internal standards for sphingolipids
#155Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
#156Compounds and methods for assaying activity of lysosomal storage diseases